Downloading...
Download

Cheapstocks

OMSE falling wedge after IPONeutral on OMSE, another relatively new ticker. Similar to my previous post on DVLT, this ticker is fundamentally strong but stuck in a falling wedge after IPO. Price is struggling to break the daily 20EMA (overlayed on this 4H chart) and has rejected multiple times. The company has strong financials, take the time to do some DD, however this pattern could break to the downside and hit new lows before we see any type of rally given the weakness in this sector at the moment. Set alerts and watch the price action play out, or don't bet your rent money on any direction if entering a position. I'm just a cat not a financial advisor.
NASDAQ:OMSE
by BorrowedClothes
27% Cheaper Than Buffett’s Buy – And Sitting on a Key ZoneHi, One of the most recent and notable additions to Berkshire Hathaway’s portfolio is Constellation Brands NYSE:STZ — and if that’s not a fundamental vote of confidence, I don’t know what is. And hey, while Midsummer Day is behind us, warm and sunny summer evenings still lie ahead. So why not make your next cold Corona or Modelo a bit more... eemmm... financially meaningful? 😄 Because let’s be honest, I’m not just sipping beer, I’m making strategic support buys to help lift the chart. 🍻 That’s right, not a simple toast but a tactical entry. Cheers to price action! ;) Okay, jokes aside, but technically, this stock is now sitting at a real make-or-break level that deserves attention. Technical View: Trendline — We’re seeing the third touch, which tends to be the strongest. I usually ignore wicks, but this time the confluence gives it weight. Monthly EMA200 — Last touched during the 2008/2009 crash. A level packed with long-term liquidity and psychological weight. Fibonacci 38% retracement Horizontal support — Marked by arrows on the chart. Price has reversed here multiple times. It’s not a coincidence and hopefully this time isn’t the exception. $150 mid-round level — US markets love round numbers, and this one sits right inside the box. Often a magnet for liquidity and reaction. -------------------------------------------------------- Now add this: You’re not just buying a chart level. You’re buying a premium cash generator: - FCF Yield ~6.8% - Operating margin ~34% - Trading ~27% cheaper than Berkshire’s initial average (their cost basis is around $220/share) - Strong brands, stable cash flows, and pricing power Yes, last earnings had a one-off impairment but the underlying business remains rock solid. If you’ve ever wanted to justify those "cold snacks" in your hand as “portfolio research”... well, here’s your excuse. Do your homework, this might be your stock today. Cheers🍻 Vaido
NYSE:STZLong
by VaidoVeek
28
Senior (SNR) LongSNR is coming off a range support. Price has been ranging since 2021 and has formed a horizontal channel between 115 and 185. I expect price to make a move to the range resistance area and possibly break higher. From a fundamental point of view: ✔ Revenue has increased year-on-year ✔ Gross and net profit margins are steady ✔ The company has sufficient cash and assets to meet its liabilities My only concern is margins are tight. If margins fall any lower, I will immediately close my positions.
LSE:SNRLong
by Samuel_Morton_Trader
Paypal - too cheap? PayPal's stock looks undervalued, trading at 6-year lows and a forward P/E ratio of 12.3, despite a strong Q1 performance with respectable transaction revenues, total payment volume, and growth in value-added services. Operating expenses are well-managed, contributing to substantial growth in operating income and earnings per share, while consensus estimates suggest mid-to-high teens EPS compound annual growth rate. Market concerns, such as PayPal's Q2 revenue guidance and increased competition, are offset by the Moderate Buy consensus rating, suggesting a 60.7% upside potential. The involvement of activist investor Elliott Management and the potential sale of the cross-border payment unit, Xoom, signal strategic changes that could enhance PayPal's performance. PayPal still rides the wave of the growth in e-commerce, with 12% payment volume increase in Q1 2023, and a rise in peer-to-peer transfers, demonstrating resilience in a challenging macroeconomic environment. The fundamentals of this company have become detached from the share price, making this a long term buy and hold with hugely asymmetrical risk/return profile. Shorter term, the move back to the highly developed Point of Control would represent over 20% growth, which I see as a high probability outcome within weeks.
NASDAQ:PYPLLong
by HayeTrading
8
DIDI: THE UBER OF CHINA ON SALE?DIDI , considered as the UBER of China , has lost 60% since its IPO day. Chinese stocks have been beaten down badly. Is this the opportunity of a lifetime to buy them cheap? I don't know. Tell me what you think. Looking at the chart, I see a triple bottom and a potential bounce play for all Chinese stock. I believe that Uber is a Didi shareholder. For these reasons I'm investing in the company for the long term . Great buy here if you can handle the regulation risk.
DLong
by Elpidaldo
2
Bullish Sector - 5G Play, Golden CrossNokia Corporation engages in the network and technology businesses worldwide. The company operates in four segments: Ultra Broadband Networks, Global Services, IP Networks and Applications, and Nokia Technologies. It focuses on mobile radio including macro radio, small cells, and cloud native radio solutions for communications service providers and enterprises; and provides network planning and optimization, network implementation, and systems integration, as well as company-wide managed services. The company also offers fixed networking solutions, such as copper and fiber access products, solutions, and services. In addition, it provides network infrastructure and professional services for mobile networks; and managed services for the fixed, mobile, Internet protocol (IP), and optical domains. Further, the company offers network planning, implementation, operation, and maintenance services. Additionally, it provides IP/optical networking solutions, including IP routing and optical transport systems, software, and services; software solutions, such as customer experience management, network operations and management, communications and collaborations, policy and charging, as well as Cloud, IoT, security, and analytics platforms; and submarine networks and radio frequency systems. The company has a strategic collaboration with Microsoft. Nokia Corporation was founded in 1865 and is headquartered in Espoo, Finland. Nokia continues receiving 5G contracts. On the Daily Chart, the 50-Day MA is ready to Cross up and over the 200-Day MA, Bullish I think NOK has a shot at reversing its downward trend real soon especially if the USA takes an ownership in the company like many White House officials have been talking about possibly doing to stop China. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NOKLong
by HotCharts
1
Merger Approved - Huge Drug Company & Dirt Cheap Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS. The company also provides prescription products, such as EpiPen Auto-Injector; Perforomist Inhalation Solution; Dymista; Creon; and Influvac, as well as YUPELRI, an inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary diseases. In addition, it markets OTC products, including Cold-EEZE, MidNite, Vivarin, Brufen, CB12, and EndWarts. The company offers its products to therapeutic areas, such as cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, gastroenterology, immunology, infectious disease, oncology, respiratory and allergy, and women's health. Its customers include retail pharmacies, wholesalers and distributors, payers, and insurers and governments, as well as institutions, such as hospitals. Mylan N.V. has collaboration and license agreements with Pfizer Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; Fujifilm Kyowa Kirin Biologics Co. Ltd; and Revance Therapeutics, Inc. The company was founded in 1961 and is based in Hatfield, the United Kingdom. Today, news that the merger with Upjohn was approved hit the news wires. www.bizjournals.com Mylan is in my opinion, one of the cheapest drug stocks in the sector at current levels. The stock currently trades at only 4x projected 2020 and 2021 earnings. The stock should be upwards of $25 to $30 a share with the merger approval. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
MLong
by HotCharts
Long Regional Banks $FISI $WSBC $FLIC $SSB (Cheap and Oversold)Hey traders, I'm buying 4 regional bank stocks today as I think they're cheap and so do the company insiders who have been buying shares like many regional bank insiders have been doing these past 2 months. The technicals have also aligned for a good entry point here imo as we're currently at the bottom of the range and oversold versus the market and financial sector in general, I'm trading off the weekly charts looking for mean reversion so these trades will need approximately 1-3 months to play out but stand to make potential 30-50% gains with less downside imo. Follow along as i'll update these trades. Jared. *Disclaimer: This is not financial advice, I'm just sharing my own trades, opinions and analysis, please trade at your own risk.
SLong
by Click-Capital
BILL ACKMAN, JOHN PAULSON & SARAH KETTERER UPS STAKE IN VIAC Here's yet more BULLISH news for VIACOMCBS (VIAC) We feel along with several other large institutional investors that VIAC is DIRT CHEAP! News Releases.. www.benzinga.com www.gurufocus.com DISCLAIMER This website and our posts are for general information only. No information, forward looking statements, or estimations presented herein represent any final determination on investment performance. While the information presented in this website and our posts has been researched and is thought to be reasonable and accurate, any investment is speculative in nature. StockKid, and/or our agents cannot and do not guarantee any rate of return or investment timeline based on the information presented herein. By reading and reviewing the information contained in this website and our posts, the user acknowledges and agrees that StockKid, and/or our agents do not assume and hereby disclaim any liability to any party for any loss or damage caused by the use of the information contained herein, or errors or omissions in the information contained in this website or our posts, to make any investment decision, whether such errors or omissions result from negligence, accident or any other cause. Investors are required to conduct their own investigations, analysis, due diligence, draw their own conclusions, and make their own decisions. Any areas concerning taxes or specific legal or technical questions should be referred to lawyers, accountants, consultants, brokers, or other professionals licensed, qualified or authorized to render such advice. In no event shall StockKid, and/or our agents be liable to any party for any direct, indirect, special, incidental, or consequential damages of any kind whatsoever arising out of the use of this website, our posts or any information contained herein. StockKid, and/or our agents specifically disclaim any guarantees, including, but not limited to, stated or implied potential profits, rates of return, or investment timelines discussed or referred to herein.
NASDAQ:PARALong
by UnknownUnicorn3159981
BABA is cheap - below all analysts targetsTechnical analysis (daily chart) RSI(10) @62 OBV on steady uptrend along with the RSI CCI(10) @100 MACD > MACDsignal Fundamental analysis BABA is a buy right now @$177. Well below analyst price average targets of $225. (Over 25%) Fair value Morningstar note Our fair value estimate is $240 per ADS incorporates management's full-year fiscal 2020 outlook calling for over CNY 500 billion in revenue (representing 33% growth year over year). * Meaning... If they achieve this growth, the price target will make sense. Good luck! dorfmanmaster
NYSE:BABALong
by dorfmanmaster
OMXH - Dovre - Cent-stocksCompany in bad finance for a couple of years. Seems to be soon at it's last legs. Common pattern: Company stock drops to downtrend channel and bounces in average 26% up from there to commence yet another new drop to the abyss (average drops +-28-33%). It's a risky stock, but if charts are true, when oversold hits and price touches downtrend channel there is a possibility to get 25-30% gains. Average downtrend length: 308d Average uptrend impulse length: x+2 aka. 6, 8, 10, 12... Traditional 3-descending peaks, so remember, very risky in case no positive news heard after 3rd peak. Not trading advice. Just observations.
OMXHEX:DOV1V
by scilentor